Literature DB >> 21437198

Influences of Comorbid Disorders on Personality Assessment Inventory Profiles in Women with Posttraumatic Stress Disorder.

Pamela Drury1, Patrick S Calhoun, Christina Boggs, Gustavo Araujo, Michelle F Dennis, Jean C Beckham.   

Abstract

The present study describes Personality Assessment Inventory (PAI) profiles for women with posttraumatic stress disorder (PTSD). Four groups of women were sampled: single Axis I diagnosis of PTSD; PTSD and major depressive disorder (MDD); PTSD, MDD, at least one other Axis I disorder; and controls with no Axis I disorder. Higher comorbidity rates were associated with higher mean profile elevations and broader range of endorsed symptoms. The group with the highest rate of comorbidity produced profiles most similar to previously published reports of patients with PTSD. This is in contrast to women with a single diagnosis of PTSD, who produced relative mean elevations only on subscales measuring distress caused by trauma and physiological symptoms of depression. Thus, published profiles may be more reflective of PTSD with comorbidity than a single diagnosis of PTSD.

Entities:  

Year:  2009        PMID: 21437198      PMCID: PMC3062164          DOI: 10.1007/s10862-008-9101-5

Source DB:  PubMed          Journal:  J Psychopathol Behav Assess        ISSN: 0882-2689


  11 in total

1.  Feigning combat-related posttraumatic stress disorder on the personality assessment inventory.

Authors:  P S Calhoun; K S Earnst; D D Tucker; A C Kirby; J C Beckham
Journal:  J Pers Assess       Date:  2000-10

Review 2.  Posttraumatic stress disorder and comorbidity: recognizing the many faces of PTSD.

Authors:  K T Brady
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

3.  Validity of the Personality Assessment Inventory Aggression scales and Violence Potential index in veterans with PTSD.

Authors:  Eric F Crawford; Patrick S Calhoun; Loretta E Braxton; Jean C Beckham
Journal:  J Pers Assess       Date:  2007-02

4.  Post-traumatic stress disorder: evidence for diagnostic validity and methods of psychological assessment.

Authors:  T M Keane; J Wolfe; K L Taylor
Journal:  J Clin Psychol       Date:  1987-01

5.  Post-traumatic stress disorder: findings from the Australian National Survey of Mental Health and Well-being.

Authors:  M Creamer; P Burgess; A C McFarlane
Journal:  Psychol Med       Date:  2001-10       Impact factor: 7.723

Review 6.  The development of a Clinician-Administered PTSD Scale.

Authors:  D D Blake; F W Weathers; L M Nagy; D G Kaloupek; F D Gusman; D S Charney; T M Keane
Journal:  J Trauma Stress       Date:  1995-01

7.  Psychiatric morbidity and comorbidity following accidental man-made traumatic events: incidence and risk factors.

Authors:  M Maes; J Mylle; L Delmeire; C Altamura
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2000       Impact factor: 5.270

8.  Assessment of a new self-rating scale for post-traumatic stress disorder.

Authors:  J R Davidson; S W Book; J T Colket; L A Tupler; S Roth; D David; M Hertzberg; T Mellman; J C Beckham; R D Smith; R M Davison; R Katz; M E Feldman
Journal:  Psychol Med       Date:  1997-01       Impact factor: 7.723

9.  Posttraumatic stress disorder comorbid with major depression: factors mediating the association with suicidal behavior.

Authors:  Maria Oquendo; David A Brent; Boris Birmaher; Laurence Greenhill; David Kolko; Barbara Stanley; Jamie Zelazny; Ainsley K Burke; Sekip Firinciogullari; Steven P Ellis; J John Mann
Journal:  Am J Psychiatry       Date:  2005-03       Impact factor: 18.112

10.  Traumatic events and posttraumatic stress disorder in an urban population of young adults.

Authors:  N Breslau; G C Davis; P Andreski; E Peterson
Journal:  Arch Gen Psychiatry       Date:  1991-03
View more
  1 in total

1.  Diagnostic efficiency of the personality assessment inventory LOGIT function for posttraumatic stress disorder in women.

Authors:  Patrick S Calhoun; Christina D Boggs; Eric F Crawford; Jean C Beckham
Journal:  J Pers Assess       Date:  2009-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.